DarioHealth extends mandatory conversion period for Series C preferred stock from 15 to 24 months

DarioHealth Corp.

Mandatory conversion period extended from 15 to 24 months for Series C, C-1, C-2 preferred stock.
Preferred holders will receive a quarterly dividend of 15% of common shares issuable upon conversion.
No new securities were issued or sold as a result of the amendment.
Amended and restated certificates of designation filed on May 20, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

DarioHealth Corp.: Amended the Series C, C-1, and C-2 Certificates of Designation to extend the mandatory conversion period from 15 to 24 months and add a quarterly dividend of 15% of Common Stock issuable upon conversion (effective 2025-05-20).

Change: charter amendment
Effective: 2025-05-20

Exact text from the filing

On May 20, 2025, DarioHealth Corp. (the “Company”), upon obtaining the vote of a majority of the holders of the relevant classes of preferred stock, filed an Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Company’s Series C Preferred Stock

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

DarioHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-25-051292

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.